Biotech · Private company
Spur Therapeutics
Track this companyFree. Adds Spur Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- FLT201Phase 3 · Gaucher Disease Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- FLT190Phase 2 · Fabry DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- verbrinacogene setparvovecPhase 2 · Hemophilia BClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Gaucher Disease Gene Therapy Trial With FLT201PHASE3 · RECRUITING · started Apr 7, 2026ClinicalTrials.gov NCT07223944 · fetched Nov 12, 2026
- Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started May 13, 2024ClinicalTrials.gov NCT06545136 · fetched Nov 12, 2026
- A Gene Therapy Study in Patients With Gaucher Disease Type 1PHASE1 · COMPLETED · started Apr 15, 2022ClinicalTrials.gov NCT05324943 · fetched Nov 12, 2026
- Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia BPHASE1_PHASE2 · TERMINATED · started Dec 6, 2021ClinicalTrials.gov NCT05164471 · fetched Nov 12, 2026
- AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)COMPLETED · started Feb 14, 2020ClinicalTrials.gov NCT04272554 · fetched Nov 12, 2026
- A Fabry Disease Gene Therapy StudyPHASE1_PHASE2 · TERMINATED · started Jul 8, 2019ClinicalTrials.gov NCT04040049 · fetched Nov 12, 2026